Advancing mRNA-LNP Technology to Enable Safer and More Effective CAR Cell Therapies
- Explore how mRNA-LNP platforms enhance the precision and safety of CAR cell engineering
- Review preclinical advances demonstrating improved efficacy and reduced toxicity in CAR-based therapies
- Understand the translational potential of transient mRNA delivery to overcome current limitations in cell therapy